ArticleScientific reports2025
The first molecular study of Cystoisospora belli and Cyclospora cayetanensis in HIV/AIDS patients from Northern Iran.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cystoisospora belli and Cyclospora cayetanensis have been known to cause a range of gastrointestinal and systemic complications, particularly in HIV/AIDS patients with low immunity. The manifestations are more severe in patients with CD4 + T-cell counts below 200 cells/µl. The current study was performed to detect these parasitic infections in HIV-positive patients in northern Iran. This cross-sectional study analyzed 50 stool samples from HIV-positive patients attending behavioral disease counseling centers in Mazandaran province, northern Iran. Following informed consent, the samples were tested for C. cayetanensis and C. belli using polymerase chain reaction (PCR) testing. Among 50 stool samples tested, 8% [95% CI: 0.48-15.52] (n = 4) were positive for C. belli while 4% [95% CI: 0.00-9.43] (n = 2) were positive for C. cayetanensis. Also infection with C. belli showing a significant association with gastrointestinal symptoms (p < 0.05). Moreover, 52% of patients reported gastrointestinal issues, primarily diarrhea and abdominal cramps. The majority of individuals (66%) resided in rural villages, and more than half (56%) were under 50 years old. Notably, 52% had CD4 + T-cell counts below 500 cells/mL. Detecting these pathogens highlights their continued public health significance, especially in rural populations. Notably, a significant association was observed between C. belli infection and gastrointestinal symptoms, emphasizing the need for early diagnosis and clinical vigilance. Given the burden of these infections, targeted screening and preventive strategies should be prioritized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.